Heparan sulphate biosynthesis and disease

Journal of Biochemistry

Volumn 144, Issue 1, 2008, Pages 7-14

  Nadanaka, Satomi ^a   Kitagawa, Hiroshi ^a,b  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Glycosyltransferase; Heparan sulphate; Hereditary multiple exostoses; Proteoglycan; Tumour suppressor gene

Indexed keywords

GROWTH FACTOR; HEPARAN SULFATE; MORPHOGEN; PROTEOGLYCAN;

BIOSYNTHESIS; BONE DISEASE; CELL FUNCTION; DEGENERATIVE DISEASE; EXTRACELLULAR MATRIX; GENE FUNCTION; HEREDITARY MULTIPLE EXOSTOSIS; METABOLIC DISORDER; MOLECULAR INTERACTION; MULTIGENE FAMILY; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

ANIMALS; BONE DISEASES; CARBOHYDRATE SEQUENCE; EXOSTOSES, MULTIPLE HEREDITARY; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; HYPERLIPOPROTEINEMIAS; MICE; MOLECULAR SEQUENCE DATA; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASMS; NEURODEGENERATIVE DISEASES;

ANIMALIA;

EID: 46849088581     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvn040     Document Type: Short Survey

References (56)

1. Kreuger, J., Spillmann, D., Li, J.P., and Lindahl, U. (2006) Interactions between heparan sulfate and proteins: the concept of specificity. J. Cell Biol. 174, 323-327
2. Gorsi, B. and Stringer, S.E. (2007) Tinkering with heparan sulfate sulfation to steer development. Trends Cell Biol. 17, 173-177
3. Bishop, J.R., Schuksz, M., and Esko, J.D. (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030-1037
4. Pan, Y., Woodbury, A., Esko, J.D., Grobe, K., and Zhang, X. (2006) Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. Development 133, 4933-4944
5. Perrimon, N. and Bernfield, M. (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404, 725-728
6. MacArthur, J.M., Bishop, J.R., Stanford, K.I., Wang, L., Bensadoun, A., Witztum, J.L., and Esko, J.D. (2007) Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J. Clin. Invest. 117, 153-164
7. Solomon, L. (1964) Hereditary Multiple Exostosis. Am. J. Hum. Genet. 16, 351-363
8. Schmale, G.A., Conrad, E.U.3rd, and Raskind, W.H. (1994) The natural history of hereditary multiple exostoses. J. Bone Joint Surg. Am. 76, 986-992
9. Hecht, J.T., Hogue, D., Strong, L.C., Hansen, M.F., Blanton, S.H., and Wagner, M. (1995) Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am. J. Hum. Genet. 56, 1125-1131
10. Saito, T., Seki, N., Yamauchi, M., Tsuji, S., Hayashi, A., Kozuma, S., and Hori, T. (1998) Structure, chromosomal location, and expression profile of EXTR1 and EXTR2, new members of the multiple exostoses gene family. Biochem. Biophys. Res. Commun. 243, 61-66
11. Van Hul, W., Wuyts, W., Hendrickx, J., Speleman, F., Wauters, J., De Boulle, K., Van Roy, N., Bossuyt, P., and Willems, P.J. (1998) Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family. Genomics 47, 230-237
12. Wise, C.A., Clines, G.A., Massa, H., Trask, B.J., and Lovett, M. (1997) Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. Genome Res. 7, 10-16
13. Wuyts, W., Van Hul, W., Hendrickx, J., Speleman, F., Wauters, J., De Boulle, K., Van Roy, N., Van Agtmael, T., Bossuyt, P., and Willems, P.J. (1997) Identification and characterization of a novel member of the EXT gene family, EXTL2. Eur. J. Hum. Genet. 5, 382-389
14. Mizumoto, S., Uyama, T., Mikami, T., Kitagawa, H., and Sugahara, K. (2005) Biosynthetic pathways for differential expression of functional chondroitin sulfate and heparan sulfate. Handbook of Carbohydrate Engineering (Yarema, K.J., ed.) pp. 289-324, CRC Press (Taylor & Francis Group), Boca Raton, FL.
15. Sugahara, K. and Kitagawa, H. (2000) Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr. Opin. Struct. Biol. 10, 518-527
16. McCormick, C., Leduc, Y., Martindale, D., Mattison, K., Esford, L.E., Dyer, A.P., and Tufaro, F. (1998) The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat. Genet. 19, 158-161
17. Lind, T., Tufaro, F., McCormick, C., Lindahl, U., and Lidholt, K. (1998) The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J. Biol. Chem. 273, 26265-26268
18. Senay, C., Lind, T., Muguruma, K., Tone, Y., Kitagawa, H., Sugahara, K., Lidholt, K., Lindahl, U., and Kusche-Gullberg, M. (2000) The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis. EMBO Rep. 1, 282-286
19. McCormick, C., Duncan, G., Goutsos, K.T., and Tufaro, F. (2000) The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc. Natl. Acad. Sci. USA 97, 668-673
20. Kim, B.T., Kitagawa, H., Tanaka, J., Tamura, J., and Sugahara, K. (2003) In vitro heparan sulfate polymerization: crucial roles of core protein moieties of primer substrates in addition to the EXT1-EXT2 interaction. J. Biol. Chem. 278, 41618-41623
21. Kitagawa, H., Shimakawa, H., and Sugahara, K. (1999) The tumor suppressor EXT-like gene EXTL2 encodes an alpha1,4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region. The key enzyme for the chain initiation of heparan sulfate. J. Biol. Chem. 274, 13933-13937
22. Kim, B.T., Kitagawa, H., Tamura, J., Saito, T., Kusche-Gullberg, M., Lindahl, U., and Sugahara, K. (2001) Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/heparin biosynthesis. Proc. Natl. Acad. Sci. USA 98, 7176-7181
23. Lidholt, K., Weinke, J.L., Kiser, C.S., Lugemwa, F.N., Bame, K.J., Cheifetz, S., Massague, J., Lindahl, U., and Esko, J.D. (1992) A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc. Natl. Acad. Sci. USA 89, 2267-2271
24. Fritz, T.A., Gabb, M.M., Wei, G., and Esko, J.D. (1994) Two N-acetylglucosaminyltransferases catalyze the biosynthesis of heparan sulfate. J. Biol. Chem. 269, 28809-28814
25. Kobayashi, S., Akiyama, T., Nata, K., Abe, M., Tajima, M., Shervani, N.J., Unno, M., Matsuno, S., Sasaki, H., Takasawa, S., and Okamoto, H. (2000) Identification of a receptor for reg (regenerating gene) protein, a pancreatic beta-cell regeneration factor. J. Biol. Chem. 275, 10723-10726
26. Nata, K., Ikada, T., Takahashi, I., Noguchi, N., Yoshikawa, T., Yamauchi, A., Sugihara, K., Asano, M., Unno, M., Takasawa, S., and Okamoto, H. (2006) Targeted disruption of mouse Reg protein receptor gene causes impaired pancreatic islet cell replication and embryonic lethality. IUBMB 565
27. Lin, X., Wei, G., Shi, Z., Dryer, L., Esko, J.D., Wells, D.E., and Matzuk, M.M. (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev. Biol. 224, 299-311
28. Stickens, D., Zak, B.M., Rougier, N., Esko, J.D., and Werb, Z. (2005) Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development 132, 5055-5068
29. Busse, M., Feta, A., Presto, J., Wilen, M., Gronning, M., Kjellen, L., and Kusche-Gullberg, M. (2007) Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. J. Biol. Chem. 282, 32802-32810
30. Kitagawa, H., Egusa, N., Tamura, J.I., Kusche-Gullberg, M., Lindahl, U., and Sugahara, K. (2001) rib-2, a Caenorhabditis elegans homolog of the human tumor suppressor EXT genes encodes a novel alpha1,4-N-acetylglucosaminyltransferase involved in the biosynthetic initiation and elongation of heparan sulfate. J. Biol. Chem. 276, 4834-4838
31. Kitagawa, H., Izumikawa, T., Mizuguchi, S., Dejima, K., Nomura, K.H., Egusa, N., Taniguchi, F., Tamura, J., Gengyo-Ando, K., Mitani, S., Nomura, K., and Sugahara, K. (2007) Expression of rib-1, a Caenorhabditis elegans homolog of the human tumor suppressor EXT genes, is indispensable for heparan sulfate synthesis and embryonic morphogenesis. J. Biol. Chem. 282, 8533-8544
32. Bornemann, D.J., Duncan, J.E., Staatz, W., Selleck, S., and Warrior, R. (2004) Abrogation of heparan sulfate synthesis in Drosophila disrupts the Wingless, Hedgehog and Decapentaplegic signaling pathways. Development 131, 1927-1938
33. Takei, Y., Ozawa, Y., Sato, M., Watanabe, A., and Tabata, T. (2004) Three Drosophila EXT genes shape morphogen gradients through synthesis of heparan sulfate proteoglycans. Development 131, 73-82
34. Han, C., Belenkaya, T.Y., Khodoun, M., Tauchi, M., Lin, X., and Lin, X. (2004) Distinct and collaborative roles of Drosophila EXT family proteins in morphogen signalling and gradient formation. Development 131, 1563-1575
35. Izumikawa, T., Egusa, N., Taniguchi, F., Sugahara, K., and Kitagawa, H. (2006) Heparan sulfate polymerization in Drosophila. J. Biol. Chem. 281, 1929-1934
36. Kim, B.T., Kitagawa, H., Tamura Ji, J., Kusche-Gullberg, M., Lindahl, U., and Sugahara, K. (2002) Demonstration of a novel gene DEXT3 of Drosophila melanogaster as the essential N-acetylglucosamine transferase in the heparan sulfate biosynthesis: chain initiation and elongation. J. Biol. Chem. 277, 13659-13665
37. Koziel, L., Kunath, M., Kelly, O.G., and Vortkamp, A. (2004) Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification. Dev. Cell 6, 801-813
38. Yamada, S., Busse, M., Ueno, M., Kelly, O.G., Skarnes, W.C., Sugahara, K., and Kusche-Gullberg, M. (2004) Embryonic fibroblasts with a gene trap mutation in Ext1 produce short heparan sulfate chains. J. Biol. Chem. 279, 32134-32141
39. Inatani, M., Irie, F., Plump, A.S., Tessier-Lavigne, M., and Yamaguchi, Y. (2003) Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science 302, 1044-1046
40. Stickens, D., Brown, D., and Evans, G.A. (2000) EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis. Dev. Dyn. 218, 452-464
41. Shimo, T., Gentili, C., Iwamoto, M., Wu, C., Koyama, E., and Pacifici, M. (2004) Indian hedgehog and syndecans-3 coregulate chondrocyte proliferation and function during chick limb skeletogenesis. Dev. Dyn. 229, 607-617
42. Ropero, S., Setien, F., Espada, J., Fraga, M.F., Herranz, M., Asp, J., Benassi, M.S., Franchi, A., Patino, A., Ward, L.S., Bovee, J., Cigudosa, J.C., Wim, W., and Esteller, M. (2004) Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells. Hum. Mol. Genet. 13, 2753-2765
43. Li, J., Shworak, N.W., and Simons, M. (2002) Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites. J. Cell Sci. 115, 1951-1959
44. Reiland, J., Kempf, D., Roy, M., Denkins, Y., and Marchetti, D. (2006) FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells. Neoplasia 8, 596-606
45. Fuster, M.M., Wang, L., Castagnola, J., Sikora, L., Reddi, K., Lee, P.H., Radek, K.A., Schuksz, M., Bishop, J.R., Gallo, R.L., Sriramarao, P., and Esko, J.D. (2007) Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J. Cell Biol. 177, 539-549
46. Verdier, Y., Zarandi, M., and Penke, B. (2004) Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J. Pept. Sci. 10, 229-248
47. van Horssen, J., Wesseling, P., van den Heuvel, L.P., de Waal, R.M., and Verbeek, M.M. (2003) Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders. Lancet Neurol. 2, 482-492
48. Giulian, D., Haverkamp, L.J., Yu, J., Karshin, W., Tom, D., Li, J., Kazanskaia, A., Kirkpatrick, J., and Roher, A.E. (1998) The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease. J. Biol. Chem. 273, 29719-29726
49. Schulz, J.G., Megow, D., Reszka, R., Villringer, A., Einhaupl, K.M., and Dirnagl, U. (1998) Evidence that glypican is a receptor mediating beta-amyloid neurotoxicity in PC12 cells. Eur. J. Neurosci. 10, 2085-2093
50. McLaurin, J., Franklin, T., Zhang, X., Deng, J., and Fraser, P.E. (1999) Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. Eur. J. Biochem. 266, 1101-1110
51. Iivonen, S., Helisalmi, S., Mannermaa, A., Alafuzoff, I., Lehtovirta, M., Soininen, H., and Hiltunen, M. (2003) Heparan sulfate proteoglycan 2 polymorphism in Alzheimer's disease and correlation with neuropathology. Neurosci. Lett. 352, 146-150
52. Li, J.P., Galvis, M.L., Gong, F., Zhang, X., Zcharia, E., Metzger, S., Vlodavsky, I., Kisilevsky, R., and Lindahl, U. (2005) In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. Proc. Natl. Acad. Sci. USA 102, 6473-6477
53. Kisilevsky, R., Szarek, W.A., Ancsin, J., Bhat, S., Li, Z., and Marone, S. (2003) Novel glycosaminoglycan precursors as anti-amyloid agents, part III. J. Mol. Neurosci. 20, 291-297
54. Kahle, P.J. and Haass, C. (2004) How does parkin ligate ubiquitin to Parkinson's disease? EMBO Rep. 5, 681-685
55. Liu, I.H., Uversky, V.N., Munishkina, L.A., Fink, A.L., Halfter, W., and Cole, G.J. (2005) Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation. Glycobiology 15, 1320-1331
56. Rohlmann, A., Gotthardt, M., Hammer, R.E., and Herz, J. (1998) Inducible inactivation of hepatic LRP gene by cremediated recombination confirms role of LRP in clearance of chylomicron remnants. J. Clin. Invest. 101, 689-695